InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Juda Scott, 董事. Director active across 1 company, notably Inmune Bio, Inc.. Cumulatively, 6 filings have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €341k. Activity tracked since 17 November 2021. The latest transaction was filed on 2 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Scott Juda is a Director at Inmune Bio, Inc. In this role, he participates in strategic decision-making and governance of the company. His experience in the biotechnology sector allows him to provide valuable insights to the board.